newsfilter
← Latest News
PR Newswire·

Inhibrx Announces $200 Million Private Placement Financing

SAN DIEGO, Aug. 29, 2023 /PRNewswire/ -- Inhibrx, Inc. (NASDAQ:INBX) ("Inhibrx" or the "Company"), a clinical-stage biopharmaceutical company dedicated to the development of therapeutics for oncology and